To deal with rising costs, employers are leveraging high performance networks, variable copay plans and exclusive provider organization plans.

BioNTech is acquiring CureVac in a deal that brings messenger RNA manufacturing capability and cancer immunotherapy ...

The letter is an extraordinary rebuke of the Trump administration’s actions against the NIH, which include: terminating hundreds of grants funding scientific and biomedical research; firing more than ...

Arkansas became the first state to pass a law banning pharmacy benefit managers from owning pharmacies, aiming to curb their market power and reduce drug costs. But major PBMs like CVS and Express ...

If enacted, the GOP’s spending bill could kick more than 10 million Americans off Medicaid. Experts are worried about the ...

Eli Lilly is partnering with Camurus, a company with technology that extends how long an injectable drug lasts in the body, ...

When Covid-19 vaccines roll out for the fall and winter respiratory illness season, they will continue to be based on the same lineage that is the basis for vaccines from this past season, but ...

Gaining greater insight into the patient journey from diagnosis through treatment is a priority for drug developers as they seek to produce more effective drugs. Using non-small cell lung cancer ...

President Trump’s latest strategy to tackle high drug prices aims to tie the price of U.S. prescription medicines to the prices paid for the same products in other countries, a so-called “most ...

Proposed Medicaid work requirements may greatly limit access to health coverage, lead to substantial economic losses, and fall short of boosting employment, a new report warns. The report was ...

The connection between climate and physical health is evident. We know, for instance, that asthma is exacerbated by exposure to wildfire smoke that occurs more commonly during hot, dry, windy ...